Section Arrow
Quote
IART.NASDAQ
- Integra LifeSciences Holdings Corp
Quotes are at least 15-min delayed:2025/02/01 11:51 EST
Last
 26.1
-0.24 (-0.91%)
Day High 
26.575 
Prev. Close
26.34 
1-M High
27.13 
Volume 
660.10K 
Bid
25.4
Ask
26.8
Day Low
25.97 
Open
26.34 
1-M Low
21.26 
Market Cap 
2.03B 
Currency USD 
P/E 78.9 
%Yield -- 
10-SMA 25.38 
20-SMA 23.86 
50-SMA 23.56 
52-W High 45.42 
52-W Low 16.805 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.09/2.49
Enterprise Value
3.68B
Balance Sheet
Book Value Per Share
19.72
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
1.54B
Operating Revenue Per Share
19.99
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SENSSenseonics Holdings0.9608-0.1292-11.85%-- 
QSIQuantum-Si1.98+0.02+1.02%-- 
PACBPacific Biosciences of California1.54-0.06-3.75%-- 
MDTMedtronic plc90.82-1.17-1.27%28.13PE
ABTAbbott Laboratories127.93-0.88-0.68%39.2PE
Quotes are at least 15-min delayed：2025/02/01 11:51 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.